Overview

A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

Status:
COMPLETED

Trial end date:
2024-08-08

Target enrollment:

Participant gender:

Summary

This study compares the efficacy, safety, and tolerability of once-weekly GZR4 Injection versus once-daily insulin degludec in patients with type 2 diabetes mellitus in inadquete control on oral antidiabetic drug (OAD) therapy or OAD Therapy in combination with basal insulin.

Phase:

PHASE2

Details

Lead Sponsor:

Gan and Lee Pharmaceuticals, USA

Treatments:

insulin degludec